The EARLY TAVR trial investigators randomly assigned patients with asymptomatic severe aortic stenosis to undergo either early transfemoral transcatheter aortic valve replacement (TAVR) or clinical surveillance. The primary end point was a composite of death, stroke, or unplanned hospitalization for cardiovascular causes.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transcatheter
November 26, 2024
November 21, 2024
CTSNet continued its webinar series partnership with the ASAIO Journal on November 14, 2024, by enrolling cardiac surgery and heart failure professionals engaged to discuss the topic, "Non-LVAD and Non-CRT Device Options in Heart Failure." Panelists included Amit N. Vora, MD, MPH, FACC, FSCAI, of Yale University, and Ulrich P. Jorde, MD, of Montefiore Health System.
November 21, 2024
In this meta-analysis, the authors included three randomized controlled trials (RCTs) conducted in patients with heart failure (HF) and moderate to severe functional mitral regurgitation (FMR), comparing treatment with the MitraClip device in addition to medical therapy (device arm) to medical therapy alone (control arm).
November 11, 2024
This video presents a clinical case of a 44-year-old man with severe respiratory failure and septic shock secondary to streptococcus pyogenes pneumonia. The authors describe a transfer technique from femoro-jugular veno-venous ECMO to veno-pulmonary ECMO with the ProtekDuo cannula.
November 7, 2024
Aortic stenosis is the most prevalent valvular heart condition necessitating surgical intervention, with full sternotomy (FS) traditionally being the standard approach for surgical aortic valve replacement (SAVR).
October 24, 2024
There is limited data available from randomized trials comparing outcomes between transcatheter aortic valve replacement (TAVR) and surgery in patients with different risks and follow-up periods of at least four years or longer.
October 3, 2024
Aortic stenosis affects more than 9 million people worldwide and is commonly treated with surgical aortic valve replacement (SAVR), which is known for producing excellent long-term outcomes. Recent advancements in transcatheter aortic valve replacement (TAVR) have shown noninferior or improved outcomes compared to SAVR across various risk levels.
October 2, 2024
In June 2024, a panel of cardiothoracic surgery experts gathered at Teatro delle Muse in Ancona, Italy to discuss Minimally Invasive and Trans-Catheter Interventions for patients with Mitral and Tricuspid Valve Diseases. This course was directed by Professor Marco Di Eusanio.
September 12, 2024
Researchers explore the use of a novel transcatheter electrosurgical technique, SESAME, for treating left ventricular outflow tract (LVOT) obstruction. This procedure, designed to mimic surgical myotomy, was tested on 76 patients between 2021 and 2023.
Surgical Extraction of a Watchman Device, Amplatzer Plug, and Failed Transcatheter Mitral Prosthesis
August 26, 2024
This video demonstrates the surgical extraction of a Watchman device, Amplatzer occluder, and a failed transcatheter mitral prosthesis on a seventy-eight-year-old male.